The Improved Experience You’ve Been Waiting For!
Discover the refreshed menu, enjoy the custom dashboard, and make use of the powerful stock screener to enhance your investment approach.
Explore Now
Based on the Advanced Enzyme Technologies Limited stock forecast from 1 analysts, the average analyst target price for Advanced Enzyme Technologies Limited is INR 470.00 over the next 12 months. Advanced Enzyme Technologies Limited’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Advanced Enzyme Technologies Limited is Slightly Bearish, which is based on 3 positive signals and 6 negative signals. At the last closing, Advanced Enzyme Technologies Limited’s stock price was INR 393.95. Advanced Enzyme Technologies Limited’s stock price has changed by +4.47% over the past week, +3.53% over the past month and +27.00% over the last year.
No recent analyst target price found for Advanced Enzyme Technologies Limited
No recent average analyst rating found for Advanced Enzyme Technologies Limited
Company Overview Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications, biofuels, and bio-catalysis. It provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is based in Thane, India. Address: Sun Magnetica, Thane, India, 400604 Read Less
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutriti...Read More
Frequently Asked Questions About Advanced Enzyme Technologies Limited (ADVENZYMES:NSE) Stock
Based on ratings from 1 analysts Advanced Enzyme Technologies Limited's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and hold ratings.
ADVENZYMES:NSE stock's dividend yield is 1.34%.
Our analysis grades ADVENZYMES:NSE stock's dividend yield at B. This means that ADVENZYMES:NSE stock's dividend yield is above 83% of the stocks in the Specialty Chemicals sector in the NSE exchange.
Based on this ADVENZYMES:NSE may be a good dividend stock for its sector.
Based on targets from 1 analysts, the average taret price for ADVENZYMES:NSE is INR 470.00 over the next 12 months. The maximum analyst target price is INR 470 while the minimum anlayst target price is INR 470.
ADVENZYMES:NSE stock's Price/Earning ratio is 31.95.
Our analysis grades ADVENZYMES:NSE stock's Price / Earning ratio at D. This means that ADVENZYMES:NSE stock's Price/Earning ratio is above 35% of the stocks in the Specialty Chemicals sector in the NSE exchange.
Based on this ADVENZYMES:NSE may be fairly valued for its sector
The last closing price of ADVENZYMES:NSE's stock was INR 393.95.
The most recent market capitalization for ADVENZYMES:NSE is INR 44.05B.
Based on targets from 1 analysts, the average taret price for ADVENZYMES:NSE is projected at INR 470.00 over the next 12 months.
This means that ADVENZYMES:NSE's stock price may go up by +19.30% over the next 12 months.
We can't find any ETFs which contains Advanced Enzyme Technologies Limited's stock.
As per our most recent records Advanced Enzyme Technologies Limited has 323 Employees.
Advanced Enzyme Technologies Limited's registered address is Sun Magnetica, Thane, India, 400604.
You can get more information about it from Advanced Enzyme Technologies Limited's website at https://www.advancedenzymes.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ADVENZYMES:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
